Search Within

William K Kelly

Formats
  1. Journal Article (82)
  2. Meeting Abstract (25)
  3. Book Section (6)
  4. Conference Paper (2)
Groups
  1. Department of Medicine (84)
  2. Solid Tumor Oncology Division (82)
  3. Genitourinary Oncology Service (81)
  4. Hematologic Malignancies, Division of (34)
  5. Nursing (31)
  6. GSK Faculty (24)

More Groups

People
  1. Howard Scher (76)
  2. Susan Slovin (31)
  3. Michael Morris (24)
  4. Tracy Smart-Curley (23)
  5. Lawrence Schwartz (20)
  6. Paul Marks (16)

More People

Years
  1. 2017 (1)
  2. 2016 (1)
  3. 2009 (2)
  4. 2007 (4)
  5. 2006 (4)
  6. 2005 (21)

More Years

Publications
  1. Journal of Clinical Oncology (34)
  2. Clinical Cancer Research (13)
  3. Urology (13)
  4. Cancer (9)
  5. Journal of Urology (5)
  6. Proceedings of the American Association for Cancer Research Annual Meeting (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (34)
  2. Elsevier Science, Inc. (20)
  3. American Association for Cancer Research (16)
  4. Elsevier Inc. (9)
  5. Wiley Blackwell (9)
  6. Lippincott Williams & Wilkins (4)

More Publishers

Results (115)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Potential role of histone deacetylase inhibitors in mesothelioma: Clinical experience with suberoylanilide hydroxamic acid
    Journal Article

    Krug, L. M.; Curley, T.; Schwartz, L.; Richardson, S.; Marks, P.; Chiao, J.; Kelly, W. K.
    Clinical Lung Cancer (2006)

    Fulltext@MSK | Save
  • Pharmacokinetics and toxicity of weekly docetaxel in older patients
    Journal Article

    Hurria, A.; Fleming, M. T.; Baker, S. D.; Kelly, Wm K.; Cutchall, K.; Panageas, K.; Caravelli, J.; Yeung, H.; Kris, M. G.; Gomez, J.; more...
    Clinical Cancer Research (2006)

    Fulltext@MSK | Save
  • Histone deacetylase inhibitors: New targeted anticancer drugs
    Book Section

    Marks, P. A.; Richon, V. M.; Miller, T. A.; Kelly, W. K.
    In DeVita, V. T.; Hellman, S.; Rosenberg, S. A. (Eds.) Cancer: Principles and Practice of Oncology. 7th ed (2005)

    Fulltext@MSK | Save
  • Phase 1 pharmacokinetic and pharmacodynamic trial of docetaxel and 17AAG (17-allylamino-17-demethoxygeldanamycin)
    Meeting Abstract

    Solit, D. B.; Egorin, M.; Kopil, C.; Delacruz, A.; Shaffer, D.; Slovin, S.; Morris, M.; Kelly, W. K.; Rosen, N.; Scher, H.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • The men's cycle plus docetaxel (Doc) in prostate cancer patients with rising PSAs in the non-castrate state
    Meeting Abstract

    Slovin, S. F.; Carducci, M. A.; Beekman, K. W.; Pili, R.; Eicher, C.; Kelly, W. K.; Morris, M. J.; Shaffer, D.; Eisenberger, M.; Scher, H. I.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • A phase I/II trial to assess tolerability and efficacy of RAD-001 with gefitinib in patients with glioblastoma multiforme and castrate metastatic prostate cancer
    Meeting Abstract

    Shaffer, D. R.; Abrey, L.; Beekman, K.; Morris, M.; Eicher, C.; Kelly, W. K.; Slovin, S.; Solit, D.; Rosen, N.; Scher, H. I.
    EJC Supplements (2005)

    Fulltext@MSK | Save
  • Reverse transcriptase polymerase chain reaction for prostate-specific antigen (RT-PCR PSA) responses may predict time to progression (TTP) in hormone refractory prostate cancer (HRPC) patients treated with chemotherapy
    Meeting Abstract

    Ross, R. W.; Manola, J.; Hennessy, K.; Galsky, M.; Scher, H.; Small, E.; Kelly, W. K.; Kantoff, P.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • A randomized phase II study of ixabepilone (Ix) or mitoxantrone and prednisone (MP) in patients with taxane (T)-resistant hormone refractory prostate cancer (HRPC)
    Meeting Abstract

    Rosenberg, J. E.; Kelly, W. K.; Michaelson, M. D.; Wilding, G.; Hussain, M.; Gross, M.; Small, E. J.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Phase II study of boriezomib for castrate metastatic prostate cancer (PC)
    Meeting Abstract

    Morris, M. J.; Beekman, K. W.; Kelly, W. K.; Slovin, S. F.; Shaffer, D.; Eicher, C.; Chu, E.; Curley, T.; Delacruz, A.; Scher, H. I.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Association of age, baseline characteristics, co-marbidity and toxicity in castrate metastatic prostate cancer patients (CMPC) treated with chemotherapy
    Meeting Abstract

    Fleming, M. T.; Beekman, K. W.; Warren, M.; Wilton, A.; Heller, G.; Scher, H.; Kelly, W. K.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save